Association of Hospice Agency Profit Status With Patient Diagnosis, Location of Care, and Length of Stay | End of Life | JAMA | JAMA Network
[Skip to Navigation]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 34.226.234.102. Please contact the publisher to request reinstatement.
1.
 NHPCO facts and figures: hospice care in America [2010 edition]. National Hospice and Palliative Care Organization. http://www.nhpco.org/files/public/Statistics_Research/Hospice_Facts_Figures_Oct-2010.pdf. Accessed December 17, 2010
2.
Hackbarth GM. Reforming the delivery system: MedPAC report to Congress [June 2008]. http://www.medpac.gov/documents/Jun08_EntireReport.pdf. Accessed January 10, 2011
3.
 Hospice facts and statistics [September 2009]. National Association for Home Care & Hospice. http://www.nahc.org/facts/HospiceStats09.pdf. Accessed October 10, 2010
4.
Huskamp HA, Buntin MB, Wang V, Newhouse JP. Providing care at the end of life: do Medicare rules impede good care?  Health Aff (Millwood). 2001;20(3):204-21111585168PubMedGoogle ScholarCrossref
5.
Gruneir A, Miller SC, Lapane KL, Kinzbrunner B. Hospice care in the nursing home: changes in visit volume from enrollment to discharge among longer-stay residents.  J Pain Symptom Manage. 2006;32(5):478-48717085274PubMedGoogle ScholarCrossref
6.
Carney K, Burns N, Brobst B. Hospice costs and Medicare reimbursement: an application of break-even analysis.  Nurs Econ. 1989;7(1):41-482648168PubMedGoogle Scholar
7.
Nicosia N, Reardon E, Lorenz K, Lynn J, Buntin MB. The Medicare hospice payment system: a consideration of potential refinements.  Health Care Financ Rev. 2009;30(4):47-5919719032PubMedGoogle Scholar
8.
Fitch K, Pyenson B. First and Last Days of Hospice Cost More: an Actuarial Evaluation of Hospice Benefits Provided to Medicare Beneficiaries. New York, NY: Milliman USA; 2003
9.
Cheung L, Fitch K, Pyenson B. The Costs of Hospice Care: an Actuarial Evaluation of the Medicare Hospice BenefitNew York, NY: Milliman USA; 2001
10.
Lindrooth RC, Weisbrod BA. Do religious nonprofit and for-profit organizations respond differently to financial incentives? the hospice industry.  J Health Econ. 2007;26(2):342-35717097173PubMedGoogle ScholarCrossref
11.
Lorenz KA, Ettner SL, Rosenfeld KE, Carlisle DM, Leake B, Asch SM. Cash and compassion: profit status and the delivery of hospice services.  J Palliat Med. 2002;5(4):507-51412243675PubMedGoogle ScholarCrossref
12.
 National Home and Hospice Care Survey. Centers for Disease Control and Prevention. http://www.cdc.gov/nchs/nhhcs.htm. Accessed October 8, 2010
13.
 National Home and Hospice Care Survey: survey methodology and documentation. http://www.cdc.gov/nchs/data/nhhcsd/NHHCS_NHHAS_web_documentation.pdf. Accessed October 8, 2010
14.
Christakis NA, Escarce JJ. Survival of Medicare patients after enrollment in hospice programs.  N Engl J Med. 1996;335(3):172-1788657216PubMedGoogle ScholarCrossref
15.
Campbell DE, Lynn J, Louis TA, Shugarman LR. Medicare program expenditures associated with hospice use.  Ann Intern Med. 2004;140(4):269-27714970150PubMedGoogle ScholarCrossref
16.
Hackbarth GM. Increasing the value of Medicare. http://www.medpac.gov/documents/jun06_entirereport.pdf. Accessed October 10, 2010
17.
O’Neill SM, Ettner SL, Lorenz KA. Paying the price at the end of life: a consideration of factors that affect the profitability of hospice.  J Palliat Med. 2008;11(7):1002-100818788962PubMedGoogle ScholarCrossref
18.
Carlson MD, Gallo WT, Bradley EH. Ownership status and patterns of care in hospice: results from the National Home and Hospice Care Survey.  Med Care. 2004;42(5):432-43815083103PubMedGoogle ScholarCrossref
19.
Lynn J, Harrell F Jr, Cohn F, Wagner D, Connors AF Jr. Prognoses of seriously ill hospitalized patients on the days before death: implications for patient care and public policy.  New Horiz. 1997;5(1):56-619017679PubMedGoogle Scholar
20.
Lynn J, Harrell FE, Cohn F, Hamel M, Dawson N, Wu AW. Defining the “terminally ill”: insights from SUPPORT.  Duquesne Law Rev. 1996;35(1):311-33612385311PubMedGoogle Scholar
21.
Christakis NA. Predicting patient survival before and after hospice enrollment.  Hosp J. 1998;13(1-2):71-879644394PubMedGoogle Scholar
22.
Fox E, Landrum-McNiff K, Zhong Z, Dawson NV, Wu AW, Lynn J.SUPPORT Investigators.  Evaluation of prognostic criteria for determining hospice eligibility in patients with advanced lung, heart, or liver disease: Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments.  JAMA. 1999;282(17):1638-164510553790PubMedGoogle ScholarCrossref
Original Contribution
February 2, 2011

Association of Hospice Agency Profit Status With Patient Diagnosis, Location of Care, and Length of Stay

Author Affiliations

Author Affiliations: Division of General Medicine and Primary Care (Drs Wachterman, Davis, and McCarthy), Divisions of General Medicine and Primary Care and Gerontology (Dr Marcantonio), Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts.

JAMA. 2011;305(5):472-479. doi:10.1001/jama.2011.70
Abstract

Context Medicare's per diem payment structure may create financial incentives to select patients who require less resource-intensive care and have longer hospice stays. For-profit and nonprofit hospices may respond differently to financial incentives.

Objective To compare patient diagnosis and location of care between for-profit and nonprofit hospices and examine whether number of visits per day and length of stay vary by diagnosis and profit status.

Design, Setting, and Patients Cross-sectional study using data from the 2007 National Home and Hospice Care Survey. Nationally representative sample of 4705 patients discharged from hospice.

Main Outcome Measures Diagnosis and location of care (home, nursing home, hospital, residential hospice, or other) by hospice profit status. Hospice length of stay and number of visits per day by various hospice personnel.

Results For-profit hospices (1087 discharges from 145 agencies), compared with nonprofit hospices (3618 discharges from 524 agencies), had a lower proportion of patients with cancer (34.1%; 95% CI, 29.9%-38.6%, vs 48.4%; 95% CI, 45.0%-51.8%) and a higher proportion of patients with dementia (17.2%; 95% CI, 14.1%-20.8%, vs 8.4%; 95% CI, 6.6%-10.6%) and other noncancer diagnoses (48.7%; 95% CI, 43.2%-54.1%, vs 43.2%; 95% CI, 40.0%-46.5%; adjusted P < .001). After adjustment for demographic, clinical, and agency characteristics, there was no significant difference in location of care by profit status. For-profit hospices compared with nonprofit hospices had a significantly longer length of stay (median, 20 days; interquartile range [IQR], 6-88, vs 16 days; IQR, 5-52 days; adjusted P = .01) and were more likely to have patients with stays longer than 365 days (6.9%; 95% CI, 5.0%-9.4%, vs 2.8%; 95% CI, 2.0%-4.0%) and less likely to have patients with stays of less than 7 days (28.1%; 95% CI, 23.9%-32.7%, vs 34.3%; 95% CI, 31.3%-37.3%; P = .005). Compared with cancer patients, those with dementia or other diagnoses had fewer visits per day from nurses (0.50 visits; IQR, 0.32-0.87, vs 0.37 visits; IQR, 0.20-0.78, and 0.41 visits; IQR, 0.26-0.79, respectively; adjusted P = .002) and social workers (0.15 visits; IQR, 0.07-0.31, vs 0.11 visits; IQR, 0.04-0.27, and 0.14 visits; IQR, 0.07-0.31, respectively; adjusted P < .001).

Conclusion Compared with nonprofit hospice agencies, for-profit hospice agencies had a higher percentage of patients with diagnoses associated with lower-skilled needs and longer lengths of stay.

×